Regulatory Affairs: The IND, NDA, and Post-Marketing

Attend this live, virtual training course to learn about FDA regulations and expectations for the content, submission and review of INDs and NDAs, and the importance of regulatory strategy.

Send Email 1.888.257.6457

返回 Agenda

Regulatory Affairs: Part 7: Mock FDA Meeting

Session Chair(s)

Carol H. Danielson, DrPH, MS, RAC

President, Regulatory Advantage, LLC, United States

Kevin Daniel Healy, PhD

Senior Vice President Regulatory Affairs, Entrada Therapeutics, United States

Regulatory Affairs: Part 7: Mock FDA Meeting

Regulatory Affairs: The IND, NDA, and Post-Marketing

Regulatory Affairs: Part 7: Mock FDA Meeting

Session Chair(s)

Carol H. Danielson, DrPH, MS, RAC

Kevin Daniel Healy, PhD

获得信息并保持参与